Decibel Therapeutics company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

decibeltx.com

Founded Year

2015

Stage

IPO | IPO

Total Raised

$189M

Date of IPO

2/12/2021

Market Cap

0.12B

Stock Price

4.51

About Decibel Therapeutics

Decibel Therapeutics (NASDAQ: DBTX) is a hearing company focused on discovering and developing new medicines to protect, repair, and restore hearing. By combining recent innovations in hearing science with diagnostic tools, biological insights, modeling, and therapeutic delivery techniques, Decibel is pioneering a comprehensive approach to define the underlying biological causes of hearing loss and develop a pipeline of breakthrough drugs targeted to specific indications and patients.

Decibel Therapeutics Headquarter Location

1325 Boylston Street Suite 500

Boston, Massachusetts, 02215,

United States

617-370-8701

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Decibel Therapeutics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Decibel Therapeutics is included in 1 Expert Collection, including Biopharma Tech.

B

Biopharma Tech

15,535 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Decibel Therapeutics Patents

Decibel Therapeutics has filed 12 patents.

The 3 most popular patent topics include:

  • Audiology
  • Alkylating antineoplastic agents
  • Antineoplastic drugs
patents chart

Application Date

Grant Date

Title

Related Topics

Status

7/13/2020

7/27/2021

Food additives, Antineoplastic drugs, Alkylating antineoplastic agents, Polysaccharides, Excipients

Grant

Application Date

7/13/2020

Grant Date

7/27/2021

Title

Related Topics

Food additives, Antineoplastic drugs, Alkylating antineoplastic agents, Polysaccharides, Excipients

Status

Grant

Decibel Therapeutics Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Decibel Therapeutics Rank

  • When was Decibel Therapeutics founded?

    Decibel Therapeutics was founded in 2015.

  • Where is Decibel Therapeutics's headquarters?

    Decibel Therapeutics's headquarters is located at 1325 Boylston Street, Boston.

  • What is Decibel Therapeutics's latest funding round?

    Decibel Therapeutics's latest funding round is IPO.

  • How much did Decibel Therapeutics raise?

    Decibel Therapeutics raised a total of $189M.

  • Who are the investors of Decibel Therapeutics?

    Investors of Decibel Therapeutics include Third Rock Ventures, Google Ventures, SR One, Foresite Capital, S-Cubed Capital and 14 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.